TCT 2024 Insights


 

TCT 2024 Insights: Real-World 30-Day Outcomes for the SAPIEN 3 Ultra Resilia Transcatheter Heart Valve in the Treatment of Failed Bioprosthetic Mitral Valves - A Propensity-Matched Analysis

34 views
November 11, 2024
Comments 0
Login to view comments. Click here to Login